Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.

Author: CamargoC A, EdmondsM L, PollackC V, RoweB H

Paper Details 
Original Abstract of the Article :
BACKGROUND: Systemic corticosteroid therapy is central to the management of acute asthma The use of ICS may also be beneficial in this setting. OBJECTIVES: To determine the benefit of ICS for the treatment of patients with acute asthma managed in the emergency department (ED). SEARCH STRATEGY: Ran...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD002308

データ提供:米国国立医学図書館(NLM)

Inhaled Corticosteroids: A Valuable Tool in Acute Asthma Management

Acute asthma episodes can be life-threatening, requiring prompt and effective treatment. This study explored the potential benefits of using inhaled corticosteroids (ICS) in the emergency department (ED) management of acute asthma. The researchers found that ICS, when used in addition to standard therapy, could reduce the likelihood of hospital admission in patients with acute asthma, particularly those not receiving systemic corticosteroids.

Reducing Admissions: The Benefits of Inhaled Corticosteroids

The study demonstrated that patients treated with ICS were less likely to be admitted to the hospital (OR: 0.33; 95% CI: 0.17, 0.64) compared to those not receiving ICS. This benefit was particularly evident in patients not receiving concomitant systemic steroids. Additionally, the study showed that ICS therapy resulted in small, but significant, improvements in peak expiratory flow (PEFR) and forced expiratory volume (FEV1), suggesting that ICS may also improve lung function in acute asthma.

Optimizing Asthma Care: A Multifaceted Approach

This study highlights the potential benefits of incorporating ICS into the ED management of acute asthma, particularly for patients not receiving systemic corticosteroids. However, the authors acknowledge that more research is needed to clarify the role of ICS in patients receiving concomitant systemic steroids. The findings emphasize the importance of a comprehensive approach to asthma management, considering the individual patient's needs and utilizing a range of therapeutic options to optimize patient outcomes.

Dr.Camel's Conclusion

Just as camels adapt to survive in challenging desert environments, patients with acute asthma require a tailored approach to manage their condition. This study reminds us that inhaled corticosteroids can be a valuable tool in the ED management of acute asthma, potentially reducing the need for hospital admissions and improving lung function. Continued research will help us refine our understanding of this therapeutic approach and optimize asthma care for patients.

Date :
  1. Date Completed 2001-12-07
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

11279763

DOI: Digital Object Identifier

10.1002/14651858.CD002308

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.